Search Result "Antiangiogenetics"
The Role of the Antiangiogenetic Ramucirumab in the Treatment of Advanced Non Small Cell Lung Cancer
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 3-13
Author(s): Paolo Maione,Assunta Sgambato,Francesca Casaluce,Paola Claudia Sacco,Giuseppe Santabarbara,Antonio Rossi,Cesare Gridelli
The Role of Antiangiogenetic Agents in the Treatment of Breast Cancer
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 5022-5032
Author(s): M. A. Bareschino, C. Schettino, G. Colantuoni, E. Rossi, A. Rossi, P. Maione, F. Ciardielloi, C. Gridell
Discovery and Development of Antiangiogenetic Drugs in Ovarian Cancer
Ebook: Anti-Angiogenesis Drug Discovery and Development
Volume: 2 Year: 2014
Author(s): Madon M. Maile,Evelyn Y. T. Wong,Daphne Suzin,Nicole E. Birrer,Richard T. Penson
Doi: 10.2174/9781608058662114020008
Thymidine Phosphorylase (Platelet-Derived Endothelial Cell Growth Factor) as a Target for Capecitabine: From Biology to the Bedside
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 2 Year: 2006 Page: 171-183
Author(s): Girolamo Ranieri, Aldo M. Roccaro, Angelo Vacca, Domenico Ribatti
New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung Cancer
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 32 Year: 2015 Page: 4763-4772
Author(s): Paola Claudia Sacco,Paolo Maione,Antonio Rossi,Assunta Sgambato,Francesca Casaluce,Giovanni Palazzolo,Cesare Gridelli
Thymidine Phosphorylase/Platelet-Derived Endothelial Cell Growth Factor as a Target for Capecitabine: From Biology to the Bedsid
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Girolamo Ranieri, Aldo Maria Roccaro, Angelo Vacca, Domenico Ribatti
Doi: 10.2174/978160805161811001010031
Second-line Treatment of Advanced Non-small Cell Lung Cancer Non-oncogene Addicted: New Treatment Algorithm in the Era of Novel Immunotherapy
Journal: Current Clinical Pharmacology
Volume: 13 Issue: 2 Year: 2018 Page: 76-84
Author(s): Cesare Gridelli,Paolo Antonio Ascierto,Francesco Grossi,Editta Baldini,Adolfo Favaretto,Maria Chiara Garassino,Alessandro Morabito,Maria Rita Migliorino,Antonio Rossi,Filippo de Marinis
Neoadjuvant Strategies for Triple Negative Breast Cancer: âState-of-the-artâ and Future Perspectives
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 1 Year: 2015 Page: 15-25
Author(s): Luisa Carbognin,Jenny Furlanetto,Cecilia Vicentini,Rolando Nortilli,Sara Pilotto,Matteo Brunelli,Francesca Pellini,Giovanni Paolo Pollini,Emilio Bria,Giampaolo Tortora
The Impact of New Emerging Drugs in the Treatment of Multiple Myeloma:Is there Still a Role for PBSC Transplantation?
Journal: Current Stem Cell Research & Therapy
Volume: 2 Issue: 1 Year: 2007 Page: 1-11
Author(s): Alessandro Corso, Marzia Varettoni
Emerging Role of Endoglin (CD105) as a Marker of Angiogenesis with Clinical Potential in Human Malignancies
Journal: Current Cancer Drug Targets
Volume: 3 Issue: 6 Year: 2003 Page: 427-432
Author(s): E. Fonsatti, L. Sigalotti, P. Arslan, M. Altomonte, M. Maio